This cohort study reports weak or absent associations between serum lipid levels and incident proliferative diabetic retinopathy and macular edema in patients with long-standing type 1 diabetes.
This study reports the PRPH2 c.828+3A>T splice site mutation is a frequent cause of inherited retinal dystrophies owing to the founder effect and that the likely cause of disease is the missplicing of the PRPH2 message that results in a truncated protein product.
This retrospective case-series study describes the outcomes of Give Kids Sight Day, an outreach ophthalmic care program held annually in Philadelphia, Pennsylvania, providing vision screening and immediate treatment when needed.
This retrospective cohort study finds that genetic and environmental risk factors influence the age at onset of neovascular age-related macular degeneration.
This observational cohort study finds that eyes with retinopathy due to incontinentia pigmenti should be monitored during infancy, early childhood, and throughout adulthood for the development of retinal complications.
This experimental interventional study finds that a new glaucoma drainage device has porosity similar to that of an existing device as well as similar histologic properties.
This population-based study shows that strabismus surgery has evolved into a subspecialized field of ophthalmology during the past 15 years.
This Markov cohort model study found trabeculectomy to be more cost-effective than tube insertion.
This prospective, multicenter randomized clinical trial found that patients receiving fluocinolone acetonide implants are at higher risk of increased intraocular pressure.
In this retrospective, population-based study, the incidence of vision-threatening complications after trabeculectomy during 20 years was comparable to those of shorter studies.
This single-center, prospective, cross-sectional case series found that diseased Bruch membrane in pseudoxanthoma elasticum suggests a pathogenetic role of Bruch membrane alterations for the development of reticular pseudodrusen.
This exploratory analysis found that, in eyes with center-involved diabetic macular edema and no prior open-angle glaucoma, repeated intravitreous injections of ranibizumab may increase the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
This Special Communication reports that improved outcomes for genotyped patients have not yet been demonstrated in a prospective clinical trial, and as a result, the costs and risks of routine genetic testing currently outweigh the benefits for patients with age-related macular degeneration.
Create a personal account or sign in to: